REGN Deadline Alert: SueWallSt Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026
Levi & Korsinsky LLP, operating as SueWallSt, issued a solicitation reminder regarding a class action lawsuit against Regeneron Pharmaceuticals. The lawsuit alleges Regeneron made misleading statements about the Phase III Fianlimab-Libtayo clinical trial, specifically regarding risk misrepresentations.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.